Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.
| Added by | mollevi |
|---|---|
| Group name | EquipeMY |
| Item Type | Attachment |
| Title | Texte intégral |
| URL | https://jitc.bmj.com/content/jitc/8/2/e001499.full.pdf |
| Accessed | 2020/11/18 - 16:27:47 |
| Date Added | 2020/11/18 - 15:27:47 |
| Date Modified | 2020/11/18 - 15:27:47 |
| Parent item | RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study |
Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).
U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)
Institut de Recherche en Cancérologie de